Lv6
2320 积分 2023-09-04 加入
Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States
4天前
已完结
Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
5天前
已完结
Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma
6天前
已完结
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study
6天前
已完结
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
6天前
已完结
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study
6天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
13天前
已完结
Prevalence of subclinical hypothyroidism and longitudinal thyroid-stimulating hormone changes in youth with metabolic dysfunction–associated steatotic liver disease: An observational study
2个月前
已完结
Association of Cumulative Exposure to Metabolic Score for Visceral Fat With the Risk of Cardiovascular Disease and All‐Cause Mortality: A Prospective Cohort Study
4个月前
已完结
AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review
4个月前
已完结
皖公网安备34019202002308
